US Stock MarketDetailed Quotes

Lixte Biotechnology (LIXT)

Watchlist
  • 3.980
  • +0.150+3.92%
Close Apr 23 16:00 ET
  • 3.980
  • 0.0000.00%
Post 16:10 ET
46.24MMarket Cap-3.16P/E (TTM)

Lixte Biotechnology (LIXT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
42.96%5.11M
197.40%1.82M
83.20%1.8M
-23.22%774.81K
-26.88%706.94K
-29.81%3.57M
-40.20%613.5K
-4.00%983.26K
-39.57%1.01M
-29.43%966.88K
Selling and administrative expenses
70.48%4.85M
206.29%1.77M
181.63%1.75M
-10.56%714.16K
-27.40%615.48K
-32.10%2.85M
-34.01%578.67K
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-General and administrative expense
70.48%4.85M
206.29%1.77M
181.63%1.75M
-10.56%714.16K
-27.40%615.48K
-32.10%2.85M
-34.01%578.67K
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
Research and development costs
-64.90%254.92K
49.64%52.12K
-85.98%50.7K
-71.22%60.65K
-23.19%91.46K
-19.14%726.23K
-76.64%34.83K
172.96%361.63K
-50.71%210.71K
-37.03%119.06K
Operating profit
-42.96%-5.11M
-197.40%-1.82M
-83.20%-1.8M
23.22%-774.81K
26.88%-706.94K
29.81%-3.57M
40.20%-613.5K
4.00%-983.26K
39.57%-1.01M
29.43%-966.88K
Net non-operating interest income expense
81.89%-1.77K
59.01%-1.6K
923.97%3.97K
24.78%-1.45K
37.74%-2.69K
-879.97%-9.77K
36.86%-3.91K
-92.98%388
-350.78%-1.92K
-474.96%-4.33K
Non-operating interest income
4.82%7.39K
314.64%2.15K
208.28%4.43K
-83.65%365
-84.58%441
-59.69%7.05K
-86.85%519
-75.26%1.44K
-17.72%2.23K
-42.99%2.86K
Non-operating interest expense
-45.56%9.16K
-15.25%3.76K
-56.43%457
-56.43%1.81K
-56.37%3.14K
3.62%16.82K
-56.31%4.43K
275.99%1.05K
113.24%4.15K
86.12%7.19K
Other net income (expense)
-26,351.04%-900.13K
-252,636.62%-717.77K
-5,689.84%-183.02K
267.72%581
168.10%79
-274.16%-3.4K
-91.89%-284
-2,800.00%-3.16K
-81.98%158
-108.70%-116
Gain on sale of security
-26,460.95%-903.87K
-253,953.52%-721.51K
-5,689.84%-183.02K
267.72%581
168.10%79
-274.16%-3.4K
-91.89%-284
-2,800.00%-3.16K
-81.98%158
-108.70%-116
Other non- operating income (expenses)
--3.74K
----
----
----
----
----
----
----
----
----
Income before tax
-67.58%-6.01M
-311.84%-2.54M
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
Income tax
Net income
-67.58%-6.01M
-311.84%-2.54M
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
Net income continuous Operations
-67.58%-6.01M
-311.84%-2.54M
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
Minority interest income
0
0
Net income attributable to the parent company
-67.58%-6.01M
-311.84%-2.54M
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
Preferred stock dividends
69.07K
18.71K
50.37K
Other preferred stock dividends
Net income attributable to common stockholders
-69.51%-6.08M
-314.87%-2.56M
-105.95%-2.03M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
Basic earnings per share
20.75%-1.26
-7.97%-0.2915
25.00%-0.33
35.56%-0.29
32.56%-0.29
40.23%-1.59
34.15%-0.27
10.20%-0.44
55.00%-0.45
47.56%-0.43
Diluted earnings per share
20.75%-1.26
-7.97%-0.2915
25.00%-0.33
35.56%-0.29
32.56%-0.29
40.23%-1.59
34.15%-0.27
10.20%-0.44
55.00%-0.45
47.56%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 42.96%5.11M197.40%1.82M83.20%1.8M-23.22%774.81K-26.88%706.94K-29.81%3.57M-40.20%613.5K-4.00%983.26K-39.57%1.01M-29.43%966.88K
Selling and administrative expenses 70.48%4.85M206.29%1.77M181.63%1.75M-10.56%714.16K-27.40%615.48K-32.10%2.85M-34.01%578.67K-30.29%621.63K-35.74%798.45K-28.22%847.82K
-General and administrative expense 70.48%4.85M206.29%1.77M181.63%1.75M-10.56%714.16K-27.40%615.48K-32.10%2.85M-34.01%578.67K-30.29%621.63K-35.74%798.45K-28.22%847.82K
Research and development costs -64.90%254.92K49.64%52.12K-85.98%50.7K-71.22%60.65K-23.19%91.46K-19.14%726.23K-76.64%34.83K172.96%361.63K-50.71%210.71K-37.03%119.06K
Operating profit -42.96%-5.11M-197.40%-1.82M-83.20%-1.8M23.22%-774.81K26.88%-706.94K29.81%-3.57M40.20%-613.5K4.00%-983.26K39.57%-1.01M29.43%-966.88K
Net non-operating interest income expense 81.89%-1.77K59.01%-1.6K923.97%3.97K24.78%-1.45K37.74%-2.69K-879.97%-9.77K36.86%-3.91K-92.98%388-350.78%-1.92K-474.96%-4.33K
Non-operating interest income 4.82%7.39K314.64%2.15K208.28%4.43K-83.65%365-84.58%441-59.69%7.05K-86.85%519-75.26%1.44K-17.72%2.23K-42.99%2.86K
Non-operating interest expense -45.56%9.16K-15.25%3.76K-56.43%457-56.43%1.81K-56.37%3.14K3.62%16.82K-56.31%4.43K275.99%1.05K113.24%4.15K86.12%7.19K
Other net income (expense) -26,351.04%-900.13K-252,636.62%-717.77K-5,689.84%-183.02K267.72%581168.10%79-274.16%-3.4K-91.89%-284-2,800.00%-3.16K-81.98%158-108.70%-116
Gain on sale of security -26,460.95%-903.87K-253,953.52%-721.51K-5,689.84%-183.02K267.72%581168.10%79-274.16%-3.4K-91.89%-284-2,800.00%-3.16K-81.98%158-108.70%-116
Other non- operating income (expenses) --3.74K------------------------------------
Income before tax -67.58%-6.01M-311.84%-2.54M-100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K
Income tax
Net income -67.58%-6.01M-311.84%-2.54M-100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K
Net income continuous Operations -67.58%-6.01M-311.84%-2.54M-100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K
Minority interest income 00
Net income attributable to the parent company -67.58%-6.01M-311.84%-2.54M-100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K
Preferred stock dividends 69.07K18.71K50.37K
Other preferred stock dividends
Net income attributable to common stockholders -69.51%-6.08M-314.87%-2.56M-105.95%-2.03M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K
Basic earnings per share 20.75%-1.26-7.97%-0.291525.00%-0.3335.56%-0.2932.56%-0.2940.23%-1.5934.15%-0.2710.20%-0.4455.00%-0.4547.56%-0.43
Diluted earnings per share 20.75%-1.26-7.97%-0.291525.00%-0.3335.56%-0.2932.56%-0.2940.23%-1.5934.15%-0.2710.20%-0.4455.00%-0.4547.56%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More